-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. -
Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older AdultsSchelbert EB, Cao JJ, Schelbert EB1, Arai AE et al.
-
Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct AdministrationG Mendieta, S Ben-Aicha, M Gutiérrez et al.
-
Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial InfarctionN Haider, L Boscá, HR Zandbergen et al.
-
Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress DisorderR von Känel, J-P Schmid, RE Meister-Langraf et al.
-
Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary SyndromeG Pemmasani, I Elgendy, MA Mamas et al.
-
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseM Bossard, P Gao, W Boden et al.
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin IY Sandoval, R Nowak, CR deFilippi et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
